U.S. Auto Stock News

NasdaqCM:DCTH
NasdaqCM:DCTHMedical Equipment

Delcath Systems (DCTH) First Profitable Year Tests Lofty 115.7x P/E Narrative

Delcath Systems (DCTH) has wrapped up FY 2025 with fourth quarter revenue of US$20.7 million and a basic EPS loss of US$0.05, alongside net income of US$1.9 million in the red, giving investors a mixed headline for the latest period. The company has seen revenue move from US$15.1 million in Q4 2024 to US$20.7 million in Q4 2025, while basic EPS shifted from a loss of US$0.11 to a smaller loss of US$0.05. This sets up a picture where top line scale and bottom line volatility put the focus...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

How Investors May Respond To Recursion Pharmaceuticals (RXRX) Extending Cash Runway With New Equity Programs

On February 25, 2026, Recursion Pharmaceuticals reported full-year 2025 results showing revenue of US$74.68 million, a net loss of US$644.76 million, and simultaneously filed a US$300 million at-the-market follow-on offering plus a US$68.57 million shelf registration for 19,424,000 Class A shares tied to employee plans. Alongside beating fourth-quarter loss and revenue expectations, management stated that cost controls and partnerships have extended Recursion’s cash runway into early 2028...
NasdaqGS:MYRG
NasdaqGS:MYRGConstruction

MYR Group (MYRG) Margin Reset To 3.2% Challenges Mixed Long Term Earnings Narrative

MYR Group (MYRG) has wrapped up FY 2025 with fourth quarter revenue of US$973.5 million and basic EPS of US$2.35, while trailing twelve month revenue sits at about US$3.7 billion with basic EPS of US$7.57, setting a clear earnings season marker for investors. The company has seen quarterly revenue move from US$829.8 million in Q4 2024 to US$973.5 million in Q4 2025, with basic EPS over that span shifting from US$0.99 to US$2.35. Trailing net profit margin sits at 3.2% versus 0.9% a year...
NYSE:HGV
NYSE:HGVHospitality

Hilton Grand Vacations (HGV) Thin 1.6% Net Margin Tests Bullish Earnings Growth Narrative

Hilton Grand Vacations FY 2025 Earnings Snapshot Hilton Grand Vacations (HGV) closed out FY 2025 with fourth quarter revenue of US$1.3b and basic EPS of US$0.56, alongside net income of US$48m. For the year, trailing twelve month EPS reached US$0.90 on revenue of US$5.0b and net income of US$81m. The company reported an increase in quarterly revenue from US$1.1b and EPS of US$0.20 in Q4 2024 to US$1.3b and EPS of US$0.56 in Q4 2025. The latest twelve month net margin is 1.6%, compared with...
NYSE:DCI
NYSE:DCIMachinery

Donaldson Company (DCI) Margin Compression Challenges Bullish Earnings Narrative In Q2 2026

Donaldson (DCI) just posted its Q2 2026 scorecard, with revenue of US$896.3 million and basic EPS of US$0.80, set against trailing twelve month revenue of US$3.8 billion and EPS of US$3.24 that frame the latest quarter in a broader run of results. Over recent quarters, revenue has moved between US$870 million and US$980.7 million while quarterly EPS has ranged from US$0.49 to just under US$0.99, giving investors a clearer view of how the current print sits within the recent earnings pattern...
NasdaqGS:SDGR
NasdaqGS:SDGRHealthcare Services

Schrödinger (SDGR) Swings To Q4 Profit Challenging Persistent Loss-Making Narrative

Schrödinger (SDGR) closed out FY 2025 with Q4 revenue of US$87.2 million, Basic EPS of US$0.44 and net income of US$32.5 million, marking a clear contrast with the loss making quarters that opened the year. Over the past few periods, the company has seen quarterly revenue move from US$59.6 million in Q1 2025 to US$54.8 million in Q2, US$54.3 million in Q3 and then US$87.2 million in Q4. EPS shifted from a loss of US$0.82 in Q1 to losses of US$0.59 and US$0.45 in Q2 and Q3, before turning...
NYSE:GBCI
NYSE:GBCIBanks

Glacier Bancorp (GBCI) Earnings Growth Reinforces Bullish Narratives Despite Premium P/E Concerns

Glacier Bancorp (GBCI) just closed FY 2025 with fourth quarter revenue of US$266.9 million and basic EPS of US$0.49, alongside full year trailing twelve month revenue of US$952.7 million and EPS of US$2.00 that reflected 25.7% earnings growth over the past year. Over recent periods, revenue has moved from US$802.5 million to US$952.7 million on a trailing twelve month basis, while EPS has gone from US$1.68 to US$2.00. This sets up a story that now centers on how sustainable those margins and...
NasdaqGS:VISN
NasdaqGS:VISNCommunications

Vistance Networks (VISN) Q4 Loss Tests Bullish Profitability Narrative Despite Trailing EPS Profit

Latest FY 2025 results set up a new phase for Vistance Networks (VISN) Vistance Networks (VISN) closed FY 2025 with Q4 total revenue of US$2.2 billion and basic EPS of a US$0.54 loss, while trailing twelve month EPS came in at US$1.16 on net income from ongoing operations of US$255.4 million. Over recent quarters the company has seen revenue move from US$1.17 billion in Q4 FY 2024 to US$1.11 billion in Q1 FY 2025, US$1.39 billion in Q2 and US$1.63 billion in Q3, before the Q4 step up. Over...
NasdaqGS:SEDG
NasdaqGS:SEDGSemiconductor

SolarEdge Technologies (SEDG) Quarterly Loss Of US$132 Million Tests Profit-Recovery Narrative

SolarEdge’s FY 2025 Numbers Put Profitability Back Under the Microscope SolarEdge Technologies (SEDG) closed FY 2025 with Q4 revenue of US$335.4 million and a basic EPS loss of US$2.21, alongside a quarterly net loss of US$132.1 million. On a trailing twelve month basis, revenue was US$1.18 billion with a net loss of US$405.4 million and basic EPS at a loss of US$6.88. Over recent quarters the company has seen revenue move from US$235.4 million in Q3 FY 2024 to US$196.2 million in Q4 FY 2024,...
NasdaqCM:AKBA
NasdaqCM:AKBABiotechs

Akebia Therapeutics (AKBA) Loss In Q4 2025 Tests Bullish Margin Narratives

Latest FY 2025 Results Set Up Margin Story For Akebia Therapeutics (AKBA) Akebia Therapeutics (AKBA) closed FY 2025 with Q4 revenue of US$57.6 million and a basic EPS loss of US$0.05, alongside trailing 12 month revenue of US$236.2 million and a trailing basic EPS loss of US$0.02. This puts the focus firmly on how efficiently that revenue is being converted into earnings. The company has seen quarterly revenue move from US$37.4 million in Q3 2024 to a range of US$57.3 million to US$62.5...
NasdaqGM:FATE
NasdaqGM:FATEBiotechs

Fate Therapeutics FY 2025 Loss Reduction Tests Bullish Narratives On Path To Profitability

Fate Therapeutics (FATE) closed out FY 2025 with Q4 revenue of US$1.4 million and a basic EPS loss of US$0.27, alongside a net loss of US$32.4 million. On a trailing 12 month basis, the company recorded revenue of US$6.6 million and a basic EPS loss of US$1.15 tied to a net loss of US$136.3 million. Over recent quarters, the business has seen quarterly revenue range between US$1.4 million and US$1.9 million and quarterly basic EPS losses move between US$0.27 and US$0.32. This keeps the focus...
NasdaqGS:MRVI
NasdaqGS:MRVILife Sciences

Maravai LifeSciences Holdings (MRVI) Posts US$130.8m TTM Loss Challenging Margin Recovery Narratives

Maravai LifeSciences Holdings (MRVI) has wrapped up FY 2025 with fourth quarter revenue of US$49.9 million and a basic EPS loss of US$0.25, set against a trailing twelve month loss of US$0.91 per share on revenue of US$185.7 million. Over recent quarters the company has seen revenue move from US$56.4 million in Q4 2024 to US$41.6 million in Q3 2025 and then to US$49.9 million in Q4 2025. Quarterly basic EPS has ranged from a loss of US$0.19 in Q4 2024 to losses between US$0.18 and US$0.27...
NYSE:BKH
NYSE:BKHIntegrated Utilities

Is Black Hills (BKH) Fairly Priced After Regulated Utilities Outlook And Valuation Checks?

If you are wondering whether Black Hills at around US$73.83 is offering fair value or a potential mispricing, you are not alone in asking that question right now. The stock has returned 1.0% over the last 7 days, 0.3% over 30 days, 6.0% year to date and 27.5% over 1 year, with a 36.7% return over 3 years and 50.7% over 5 years, which gives useful context before comparing price with underlying value. Recent news around Black Hills has largely focused on its position in the regulated utilities...
NYSE:ENOV
NYSE:ENOVMedical Equipment

Enovis (ENOV) FY 2025 Loss Of US$9.07 EPS Tests Margin Turnaround Narrative

Enovis (ENOV) has wrapped up FY 2025 with fourth quarter revenue of US$575.8 million and a basic EPS loss of US$9.07, alongside trailing twelve month revenue of about US$2.2 billion and a cumulative EPS loss of US$20.72. Over the past six reported quarters, revenue has moved from US$505.2 million in Q3 2024 to US$575.8 million in Q4 2025, while basic EPS has ranged from a loss of US$0.61 to a loss of US$12.06 as the business absorbed sizeable charges and ongoing losses. That mix of solid top...
NYSE:SDRL
NYSE:SDRLEnergy Services

Assessing Seadrill (SDRL) Valuation After 2025 Results Reveal Losses Contracts And 2026 Guidance

Seadrill (SDRL) is back in focus after releasing fourth quarter and full year 2025 results, combining higher reported revenues with a shift to a net loss, an impairment charge, fresh rig contracts, and 2026 revenue guidance. See our latest analysis for Seadrill. At a share price of $43.26, Seadrill has seen a 1 month share price return of 11.64% and a 90 day share price return of 41.74%. The 1 year total shareholder return of 66.32% contrasts with a 3 year total shareholder return decline of...
NasdaqGS:METC
NasdaqGS:METCMetals and Mining

Ramaco Resources (METC) Posts US$14.7 Million Q4 Loss Reinforcing Bearish Margin Concerns

Ramaco Resources (METC) closed FY 2025 with fourth quarter revenue of US$128.0 million and a net loss of US$14.7 million, equal to basic EPS of US$0.22 loss. Trailing twelve month revenue stood at US$536.6 million against a net loss of US$51.4 million or basic EPS of US$0.78 loss. The company has seen quarterly revenue range from US$120.996 million to US$152.959 million over 2025 as EPS moved between US$0.18 loss and US$0.26 loss. Investors may compare these results with existing forecasts...
NYSE:CHE
NYSE:CHEHealthcare

Chemed FY 2025 Margin Compression Challenges Bullish Hospice Growth Narrative

Chemed FY 2025 results set up a mixed margin story for investors Chemed (CHE) has wrapped up FY 2025 with fourth quarter revenue of US$639.3 million and basic EPS of US$5.48, alongside net income excluding extra items of US$76.8 million. This gives investors a clear read on its latest operating run rate. Over recent quarters the company has seen revenue move from US$606.2 million in Q3 2024 to US$646.9 million in Q1 2025 and US$639.3 million in Q4 2025. Basic EPS has ranged from US$5.04 in Q3...
NasdaqGM:MIRM
NasdaqGM:MIRMBiotechs

Mirum Pharmaceuticals (MIRM) Narrowing Losses Challenge Bearish Profitability Narratives In FY 2025 Results

FY 2025 results snapshot Mirum Pharmaceuticals (MIRM) has wrapped up FY 2025 with Q4 revenue of US$148.9 million and a basic EPS loss of US$0.11, alongside trailing twelve month revenue of US$521.3 million and a full year basic EPS loss of US$0.47. Over recent quarters the company has seen revenue move from US$99.4 million in Q4 2024 to US$148.9 million in Q4 2025, while quarterly basic EPS has ranged between a loss of US$0.50 in Q4 2024 and a small profit of US$0.06 in Q3 2025. This latest...
NYSE:USB
NYSE:USBBanks

Fresh Bond Issuance And Analyst Upgrades Might Change The Case For Investing In U.S. Bancorp (USB)

Over the past week, U.S. Bancorp has issued a series of long-dated, fixed-rate, callable senior unsecured and unsubordinated notes totaling more than US$80,000,000 in principal, across maturities from 2031 to 2046 and coupons generally between 4% and 5.65%. Alongside these bond offerings, analysts have turned more positive on U.S. Bancorp following better-than-expected earnings, with several upgrades and buy ratings highlighting improved operational performance despite ongoing growth...
NYSE:PRKS
NYSE:PRKSHospitality

United Parks And Resorts (PRKS) Margin Compression Reinforces Bearish Profitability Narrative

United Parks & Resorts (PRKS) just wrapped up FY 2025 with fourth quarter revenue of US$373.5 million and basic EPS of US$0.28, alongside net income of US$15.1 million. Over recent quarters, the company has seen revenue move between US$286.9 million and US$545.9 million, while basic EPS has ranged from a quarterly loss of US$0.29 to a peak of US$2.09. Trailing 12 month EPS sits at US$3.09 on net income of US$168.4 million from revenue of US$1.7 billion. With a trailing net margin of 10.1% and...
NYSE:BK
NYSE:BKCapital Markets

Has The Market Run Too Far On Bank of New York Mellon Corporation (BK) After 43% One-Year Gain?

Wondering if Bank of New York Mellon Corporation is reasonably priced after its strong run, or if you might be paying too much for BNY today? This article walks through that question with a clear focus on what you are getting for the current share price. BNY recently closed at US$121.61, with returns of 2.9% over the last 7 days, 2.3% over 30 days, 3.9% year to date and 42.9% over the past year, plus very large gains over 3 and 5 years at about 1.6x and just over 2x respectively. These moves...
NYSE:KGS
NYSE:KGSEnergy Services

Kodiak Gas Services (KGS) Earnings Growth And 6.2% Margin Test Recurring Revenue Narrative

Kodiak Gas Services (KGS) has just wrapped up FY 2025 with Q4 revenue of US$332.9 million and basic EPS of US$0.29, alongside trailing twelve month revenue of US$1.3 billion and EPS of US$0.92 that sit against a 61.4% earnings growth figure for the year. The company has seen revenue move from US$1.2 billion and EPS of US$0.60 on a trailing basis at the end of 2024 to the latest US$1.3 billion and US$0.92, with net profit margin at 6.2% compared with 4.3% the prior year. This puts the focus...
NasdaqGS:CRSR
NasdaqGS:CRSRTech

Corsair Gaming (CRSR) Q4 Profit Sparks Fresh Debate On Path To Sustainable Margins

Corsair Gaming FY 2025 Results Set Up a Margin Story for Investors Corsair Gaming (CRSR) closed FY 2025 with Q4 revenue of US$436.9 million and basic EPS of US$0.23, alongside trailing twelve month revenue of US$1.47 billion and a trailing basic EPS loss of US$0.12. The company has seen quarterly revenue range from US$320.1 million to US$436.9 million over the past year, while quarterly basic EPS has swung between a loss of US$0.16 and a profit of US$0.23. This puts the focus firmly on how...
NasdaqGS:SKYW
NasdaqGS:SKYWAirlines

SkyWest (SKYW) Is Up 6.6% After Earnings Upgrades And Fleet Expansion News Has The Bull Case Changed?

Recently, SkyWest drew investor attention as analysts raised earnings estimates and highlighted the airline’s expanding E175 fleet and strong operational metrics, including higher block hours and a high flight completion rate. This combination of upgraded earnings expectations and evidence of reliable performance has reinforced the view of SkyWest as a value-oriented regional carrier with improving fundamentals. Now we’ll examine how upward earnings estimate revisions, combined with fleet...